Related Experiment Video
Updated: Aug 21, 2026
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
House dust mite control measures for asthma
P C Gøtzsche1, H K Johansen, L M Schmidt
1Nordic Cochrane Centre, Rigshospitalet, Dept. 7112, Blegdamsvej 9, Copenhagen Ø, Denmark, 2100.
Background:
The major allergen in house dust comes from mites. Chemical, physical and combined methods of reducing mite allergen levels are intended to reduce asthma symptoms in people who are sensitive to house dust mites.
Objectives:
To assess the effects of reducing exposure to house dust mite antigens in the homes of people with mite-sensitive asthma.
Search Strategy:
Cochrane Airways Group trials register, and PubMed and The Cochrane Library (last searches June 2004), reference lists.
Selection Criteria:
Randomised trials of mite control measures vs placebo or no treatment in asthmatic people known to be sensitive to house dust mites.
Data Collection And Analysis:
Two reviewers applied the trial inclusion criteria, assessed their quality and extracted the data independently. Study authors were contacted to clarify information.
Main Results:
Forty-nine trials (2733 patients) were included; the number of patients has more than doubled since the last version of this review. Thirty-one trials assessed physical methods, ten assessed chemical methods, and eight a combination of chemical and physical methods. Despite the fact that many trials were of poor quality and would be expected to exaggerate the reported effect, we did not find an effect of the interventions. For the most frequently reported outcome, peak flow in the morning (1339 patients), the standardised mean difference was -0.02 (95% confidence interval (CI) -0.13 to 0.08). There were no statistically significant differences either in number of patients improved (relative risk 1.01, 95% CI 0.80 to 1.27), asthma symptom scores (standardised mean difference -0.01, 95% CI -0.10 to 0.13), or in medication usage (standardised mean difference -0.05, 95% CI -0.18 to 0.09).
Reviewers' Conclusions:
Chemical and physical methods aimed at reducing exposure to house dust mite allergens cannot be recommended. It is doubtful whether further studies, similar to the ones in our meta-analysis, are worthwhile. If other types of studies are considered, they should be methodologically rigorous and use other methods than those used so far, with careful monitoring of mite exposure and relevant clinical outcomes.
Insights
Reducing house dust mite (HDM) allergen exposure through chemical or physical methods does not effectively reduce asthma symptoms in sensitive individuals. Further research should focus on rigorous methodologies and alternative strategies for mite control in asthma management.
Area of Science:
- Allergy and Immunology
- Environmental Health
- Respiratory Medicine
Background:
- House dust mites (HDM) are a primary source of allergens contributing to asthma.
- Interventions targeting HDM allergen reduction aim to alleviate symptoms in sensitive asthmatics.
Purpose of the Study:
- To evaluate the efficacy of reducing exposure to house dust mite allergens in the homes of individuals with mite-sensitive asthma.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Inclusion criteria: Mite control measures versus placebo or no treatment in mite-sensitive asthmatics.
- Data extraction and quality assessment performed independently by two reviewers.
Main Results:
- Forty-nine trials involving 2733 patients were analyzed.
- No statistically significant improvements were observed in morning peak flow, patient-reported symptom scores, or medication usage.
- Despite numerous trials, many of poor quality, no beneficial effect of mite reduction interventions was found.
Conclusions:
- Current chemical and physical methods for reducing house dust mite allergen exposure are not recommended for asthma management.
- Further research using similar methodologies is questionable; future studies require rigorous design and novel approaches.
More Related Videos
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
01:28Asthma I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
First, in...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: